Risperdal Gynecomastia Lawsuits Move Forward, As Pennsylvania Mass Tort Program Schedules March Meeting, Bernstein Liebhard LLP Reports – satPRnews

Risperdal lawsuits involving gynecomastia (male breast growth) and other side effects allegedly associated with use of the atypical antipsychotic medication continue to move forward in the Philadelphia Court of Common Pleas, where the state’s Risperdal docket has been centralized in a mass tort program. According to a notice posted on the Court’s website, the litigation is scheduled to convene a meeting on March 9, 2017 at 11:00 a.m. (In Re: Risperdal Litigation, Case ID: 100300296)

Source: Risperdal Gynecomastia Lawsuits Move Forward, As Pennsylvania Mass Tort Program Schedules March Meeting, Bernstein Liebhard LLP Reports – satPRnews

Posted on